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Metabolism of Orally Administered
Cadmium-Metallothionein in Mice
by M. George Cherian*
The main source of cadmium in the diet is cereal or meat, especially in liver and kidney. Since the
cadmium in both liver and kidney is bound to metaflothionein, a heat-stable protein, the gastrointestinal
absorption and metabolism ofcadmium metallothionein (CdMt) was studied in detail. The selective renal
cadmium deposition afteroral CdMt wasanalogous to the studies oninjected CdMt. Metallothionein with
'09Cd or 35S-cysteine radioactive label was isolated from rat liver and administered orally (60 Ag Cd)
through a gastric tube to mice (C57 BL/6J). After 4hr, a major portionofthe ingested CdMt was isolated
intact from intestinal mucosal cells. However, only a small amount of cadmium bound metaflothionein
was present in the kidney supernatant. The protein moeity was also degraded completely in kidney. The
absorption and tissue distribution of cadmium from oral cadmium-cysteine and cadmium-glutathione
complexes were similar to that after oral CdCL2 in mice. These results suggest that oral CdMt may be
absorbed intact from the gastrointestinal tract and the protein is degraded during renal deposition.
Introduction
The critical organ in chronic cadmium toxicity is
considered to be kidney; but the various factors in-
fluencing the movement and deposition ofcadmium
in the kidney are not yet understood clearly. Studies
(1-3) on the metabolism of injected cadmium-
metallothionein (CdMt) have shown that bio-
complexes of cadmium may have a significant role
in the tissue distribution and toxicity of cadmium.
However, there is little information available re-
garding the gastrointestinal absorption of different
dietary forms of cadmium and their toxicity. The
average gastrointestinal absorption of cadmium
from food is estimated to be about 6% of the total
daily intake in humans (4). Studies (5) in human
volunteers using radioactive cadmium salts showed
that the absorption of cadmium was dependent on
the iron status ofthe individual and was increased in
iron deficiency. The deposition of cadmium in the
kidney was also increased in iron deficiency in ex-
perimental animals (5).
It is now well known that cadmium is present as a
heat-stable protein, metallothionein, in beef liver
and kidney. In view ofthe potential toxic effects of
injected CdMt on kidney (2) and its cellular toxicity
on intestine in direct perfusion experiments (6), the
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absorption and tissue distribution of oral CdMt
were studied in detail in the present investigation.
In a preliminary study (7) from our laboratory com-
paring the gastrointestinal absorption of oral cad-
mium salts and CdMt, a similar absorption of cad-
mium from these two forms was observed. How-
ever, cadmium from oral cadmium salts was prefer-
entially accumulated in the liver, whereas, the
major depot for ingested CdMt was the kidney.
Similar tissue distribution of cadmium was ob-
served after CdMt injection (1, 2). The present
study was carried out using radioactively labeled
metallothionein in both metal and protein moiety to
determine whether orally administered CdMt can
reach the small intestine intact and can be absorbed
without degradation.
Materials and Methods
Cadmium-metallothionein (CdMt) was isolated
from livers of rats injected with 0.6 mg Cd/kg as
cadmium chloride (CdCl2) and either 1'9CdCl2 or
35S-cysteine. The method of isolation of "09CdMt
and 35S-CdMt was the same as that described previ-
ously (1, 8). The final purification ofmetallothionein
was achieved by chromatography on DEAE
Sephadex A-25 columns (9) and the major metal-
lothionein fraction (DEAE II fraction) was used in
the present study. The purity of the isolated
'09CdMt and 35S-CdMt was confirmed by their elu-
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weight in calibrated Sephadex G-75 columns. The
cadmium content of these fractions was estimated
by the flameless atomic absorption method (7) and
the specific radioactivity of the isolated 109CdMt
was calculated. A solution of109CdCl2 with identical
specific activity was prepared. 109Cd-cysteine and
109Cd-glutathione complexes were prepared by
adding a four times excess molar concentration of
either cysteine or glutathione to 109CdC12 solution
and adjusting to pH 8.
Male mice of C57 BL/6J strain, 6-10 weeks old,
were obtained from Jackson laboratory. They were
fed with a commercial stock diet (Purina mouse
chow from Ralston Purina Co.). The mice were
starved overnight and one ofthe following cadmium
solutions containing 60 ug of cadmium and 2 ,uci
109Cd radioactivity in 0.2 ml was administered orally
through a stomach tube under mild ether anes-
thesia: '09CdC12, 109Cd-cysteine, 109Cd-glutathione,
'09CdMt, and35S-CdMt. All the mice were sacrificed
4 hr after oral cadmium administration, and "09Cd
radioactivity was measured in liver, kidney, spleen,
pancreas, testes, heart, and lung in all groups of
mice except the one group given 35S-CdMt. The
total amount of radioactive cadmium deposited in
organs was calculated. The intestinal contents were
washed out with cold normal saline, the proximal
one-halfofthe small intestine removed, the mucosa
was scraped off with a glass microscopic slide and
pooled in each group. The kidneys from "09CdMt
and 35S-CdMt fed mice and the intestinal mucosa
from all the different groups were homogenized in
0.25M sucrose, Tris-HCl buffer, pH 8.6. The tissue
homogenates were centrifuged at 105,000g for 1 hr,
and the postmicrosomal supernatants were frac-
tionated on calibrated Sephadex G-75 columns for
separation ofproteins. The 109Cd or35S radioactivity
ofSephadex fractions were measured ini agamma or
a liquid scintillation counter with counting efficien-
cies of45% and 90%, respectively.
Results
Figure 1 shows the Sephadex G-75 fitration pat-
terns of postmicrosomal supernatant fractions of
kidney and intestine from mice, 4 hr after oral
109CdMt and 35S-CdMt. Even though most of the
absorbed radioactive cadmium from oral CdMt was
deposited in the kidney, amajorportion ofcadmium
in the kidney supernatant was bound to high
molecular weight proteins and not to metallothio-
nein. There was also little 35S-cysteine radioactivity
associated with the renal metallothionein suggesting
considerable degradation during the initial period of
deposition in the kidney. In contrast to the renal
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FIGURE 1. Gel filtration of kidney (upper panel) and intestine
(lower panel) cytosols, 4 hr after oral administration of
109CdMt or 35S-CdMt in mice: (--) "09Cd radioactivity; (-)
35S radioactivity; ( ) optical density at 254 nm. Cytosol
samples were fractionated on calibrated Sephadex G-75 col-
umns (0.9 x 60 cm). The arrow indicates the position ofelu-
tion of metallothionein.
deposition, a major portion of the ingested metal-
lothionein was isolated intact from the intestinal
mucosa and a considerable amount of both 35S-
cysteine and "09Cd radioactivity was associated with
the metallothionein fraction. These results suggest
that at least a portion of orally administered CdMt
can reach the small intestine intact and can be reab-
sorbed without considerable degradation.
The tissue distributions of cadmium, 4 hr after a
single oral dose ofequal amounts ofcadmium in the
form of "09CdCl2, '"Cd-cysteine, "09Cd-glutathione,
and "09CdMt in mice are compared in Table 1. Ex-
cept for CdMt-fed mice, a major portion of ab-
sorbed cadmium was deposited in the liver in all
other groups. The oral administration of CdMt in
mice resulted in an increased deposition of cad-
mium in the kidney. The similar organ distribution
of cadmium from oral CdCl2, Cd-cysteine, and Cd-
glutathione suggested similar gastrointestinal ab-
sorption of cadmium from cadmium salts and these
biocomplexes.
The fractionation of the intestinal supernatant
samples from mice, 4 hr after oral CdCl2, Cd-
cysteine, Cd-glutathione, and CdMt on Sephadex
Environmental Health Perspectives 128Table 1. Tissue distribution ofcadmium after or
of different biocomplexes of cadmit
Cadmium in organ,
CdC12 Cd-Cysteine Cd-G,
Liver 257.7 ± 32 214.3 ± 35 255.8 ±
Kidney 30.5 ± 3 37.0 ± 6 33.8 +
Spleen 6.2 ± 0.9 2.6 ± 1.4 2.7 ±
Pancreas 9.9 ± 4.3 14.6 ± 4.5 13.1 ±
Testes 4.2 ± 0 3.1 ± 0.7 3.2 ±
Heart 7.1 ± 1.5 5.4 0.9 4.1 ±
Lung 5.5 ± 0.5 5.6 ± 3.2 3.9 ±
a Male mice (C57B1/6J) were starved overnil
Cd and 2,uCi of109Cd were administered as Cd(
with cysteine (2 umole) and glutathione (2 ,utmo
cadmium-metallothionein (CdMt) orally with ag
were sacrificed 4 hr later. The results are from i
group.
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FIGURE 2. Distribution of'09Cd in mice intestina
single oral administration of109Cd as CdC12 o
Cd-glutathione or Cd-metallothionein. The
rificed 4 hr after ingestion, the proximal halfc
was perfused, and the mucosal cell cytosols M
on Sephadex G-75 columns.
G-75 columns showed a similar cadn
pattern (Fig. 2) in all the different grout
cadmium binding protein in the ir
metallothionein. However, there was
amount ofcadmium bound to metallotl
mucosal cells of CdMt fed mice as
groups fed CdCl2, Cd-cysteine, and Cd
Discussion
Increased renal accumulation of ci
age has been reported in both general]
lation (10, 11) and in workmen who M
ously exposed to excessive amounts of
12). The typical feature of chronic cac
ication is the renal damage affecti
glomerular filtration and proximal t
ral administration sorption (13). However, little is known about the
UM.a metabolic and biochemical events which precede
ng the renal toxic effects of cadmium. Investigations
ng CdMt (14, 15) from our laboratory on the role ofCdMt in SH CdMt the cadmium induced nephropathy indicated that
41 18.1 ± 0.4 there were at least two distinct phases in chronic 3 130.7 ± 0.8 cadmium exposure studies in rat. The first phase
6 2.2 ± 2 was an initial tolerant phase, where CdMt was
0.9 2.0 ± 0 within the renal and hepatic cells without any cell
F 0.1 0.9 ± 0.6 injury. The second phase was a toxic phase
0 0.1 4.3 ± 0.1 characterized by detectable amounts of CdMt in
ght and 60 ,Ag of plasma and renal tubular damage. Recent studies (2,
C12or complexed 15) also revealed that the injection of CdMt can als)tricstaube Tihey bypass the initial tolerant phase. Thus, the renal
four mice in each damage in experimental cadmium toxicity may be
directly correlated to the extracellular presence of
CdMt (14).
The important factors to be considered in renal
IETALL0THIN toxicity ofcadmium are the movement ofcadmium
to the kidney and release of CdMt to the extracel-
lular compartment. The fractionation of intestinal
mucosal cells and separation of the cytosol by
Sephadex gel fitration, 4 hr after oral administra-
tion of109CdMt and 35S-CdMt, showed that a major
portion ofboth 109Cd and35S ingested radioactivities EIN were associated with intact metallothionein (Fig. 1).
These results on the recovery of intact radioactive
CdMt from the mucosal cells after oral CdMt
suggested that oral CdMt could reach the small in-
testine and was probably absorbed without much
degradation. It is not clear yet whether ingested
20 So3 40 CdMt is completely protected from degradation
with proteolytic enzymes and low pH environment
L1 cytosols aftera of the gastric content. The cadmium-bound metal-
rCd-cysteine or lothionein was subsequently released to the general
mice were sac- circulation and sequestered by the kidney, probably
rsmall intestine similar to that after parenteral administration (2). ierefractionated The mechanism oftransfer ofabsorbed CdMt from
mucosal cells to kidney is presently unknown.
nium binding However, fractionation ofthe kidney supernatant 4
ps. The major hr after oral administration ofradioactive CdMt re-
itestine was vealed considerable degradation of the protein and
an increased only trace amounts ofintact CdMt could be isolated
hionein in the from the kidney. These results were contrary to that
compared to after parenteral administration of CdMt (1) and
1-glutathione. suggested that ingested CdMt though absorbed in-
tact from the gut, was degraded considerably during
transfer to the kidney or soon afterrenal deposition.
The possible degradation of oral CdMt in the
admium with gastrointestinal tract and its subsequent absorption
human popu- as a cadmium-cysteine complex can be further
vere continu- ruled out because of the differences in tissue dis-
Fcadmium (4, tribution ofcadmium afteroral CdMtandCd-cysteine.
tmium intox- Cadmium from oral Cd-cysteine was accumu-
ing both the lated mainly in liver similar to that after CdCl2
:ubular reab- (Table 1). A major question which arises from these
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U-02 istudies is whether oral CdMt can be toxic to the
intestine and kidney. Preliminary morphological
data in our laboratory with high doses (60 ,ug Cd as
oral CdMt) showed morphological changes both in
intestine and kidney, one week after oral CdMt (un-
published data). However, more results using lower
doses of oral CdMt are needed to have a definite
conclusion on the potential toxicity oforal CdMt. It
should be mentioned that since cadmium was not
released from CdMt by heating, the dietary form of
cadmium may not be altered by cooking and for
those who consume beef liver and kidney prepara-
tions, the major dietary form of cadmium may be
metallothionein.
The direct extrapolation ofthese results on single
exposure studies in mice to dietary intake of cad-
mium in humans may be difficult because ofthe well
known interactions between cadmium and essential
metals like iron and calcium in the diet (5, 16).
However, these studies have significant implica-
tions on the importance ofdifferent dietary forms of
cadmium, especially metallothionein in the gas-
trointestinal absorption and renal deposition of
cadmium.
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